IDO1 and melanoma: Altered IDO activity is found in a wide range of human malignancies, such as breast cancer, endometrial cancer, gastric cancer, glioblastoma, lung cancer, head and neck cancer, and pancreatic cancer, hematological malignancies as well as melanoma [7,15,16].